Keli L. Hill

Array ( [id] => 1076701 [patent_doc_number] => 07615212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Compositions and methods for the systemic treatment of arthritis' [patent_app_type] => utility [patent_app_number] => 11/067335 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 6460 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615212.pdf [firstpage_image] =>[orig_patent_app_number] => 11067335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074746 [patent_doc_number] => 20050148014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Regulation of human P2Y1-like G protein-coupled receptor' [patent_app_type] => utility [patent_app_number] => 11/063894 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27479 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148014.pdf [firstpage_image] =>[orig_patent_app_number] => 11063894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233201 [patent_doc_number] => 20050256074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Methods and compositions for regulating lymphocyte activity' [patent_app_type] => utility [patent_app_number] => 11/061869 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 72006 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256074.pdf [firstpage_image] =>[orig_patent_app_number] => 11061869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7184822 [patent_doc_number] => 20050191681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Novel polynucleotides and proteins encoded thereby' [patent_app_type] => utility [patent_app_number] => 11/058709 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 58969 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191681.pdf [firstpage_image] =>[orig_patent_app_number] => 11058709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136784 [patent_doc_number] => 20050181503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom' [patent_app_type] => utility [patent_app_number] => 11/054919 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7396 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181503.pdf [firstpage_image] =>[orig_patent_app_number] => 11054919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198710 [patent_doc_number] => 20070298028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)' [patent_app_type] => utility [patent_app_number] => 10/589676 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34826 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298028.pdf [firstpage_image] =>[orig_patent_app_number] => 10589676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658283 [patent_doc_number] => 20080027145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Therapeutic Molecules and Methods for Generating and/or Selecting Same' [patent_app_type] => utility [patent_app_number] => 10/588687 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18257 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027145.pdf [firstpage_image] =>[orig_patent_app_number] => 10588687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945243 [patent_doc_number] => 20050197292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Compositions and methods for treating T-cell mediated pathological conditions' [patent_app_type] => utility [patent_app_number] => 11/047207 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 22550 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197292.pdf [firstpage_image] =>[orig_patent_app_number] => 11047207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852466 [patent_doc_number] => 20080318209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Cjd Prion Testing' [patent_app_type] => utility [patent_app_number] => 10/588078 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2635 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318209.pdf [firstpage_image] =>[orig_patent_app_number] => 10588078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613926 [patent_doc_number] => 20060115854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease' [patent_app_type] => utility [patent_app_number] => 11/038753 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5095 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115854.pdf [firstpage_image] =>[orig_patent_app_number] => 11038753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103948 [patent_doc_number] => 20050106674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Ligands for EPH-like receptors' [patent_app_type] => utility [patent_app_number] => 11/022400 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9431 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106674.pdf [firstpage_image] =>[orig_patent_app_number] => 11022400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233841 [patent_doc_number] => 20050079539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Novel gene encoding brain specific membrane protein' [patent_app_type] => utility [patent_app_number] => 11/007517 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11268 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079539.pdf [firstpage_image] =>[orig_patent_app_number] => 11007517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010448 [patent_doc_number] => 20070280927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Treatment Of Neurodegenerative Diseases By The Use Of Atp7a' [patent_app_type] => utility [patent_app_number] => 10/587426 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19169 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280927.pdf [firstpage_image] =>[orig_patent_app_number] => 10587426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198711 [patent_doc_number] => 20070298029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/659680 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13739 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298029.pdf [firstpage_image] =>[orig_patent_app_number] => 11659680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898889 [patent_doc_number] => 20080118503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Leptin Antagonist and Method for Quantitative Measurement of Leptin' [patent_app_type] => utility [patent_app_number] => 10/579203 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14218 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118503.pdf [firstpage_image] =>[orig_patent_app_number] => 10579203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793561 [patent_doc_number] => 20060014242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)' [patent_app_type] => utility [patent_app_number] => 10/987856 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 40398 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014242.pdf [firstpage_image] =>[orig_patent_app_number] => 10987856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326309 [patent_doc_number] => 07514079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Antibodies that specifically bind to neurokinin B' [patent_app_type] => utility [patent_app_number] => 10/981692 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51006 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514079.pdf [firstpage_image] =>[orig_patent_app_number] => 10981692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189051 [patent_doc_number] => 20070167360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Methods for treating multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 10/577506 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12537 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167360.pdf [firstpage_image] =>[orig_patent_app_number] => 10577506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6917685 [patent_doc_number] => 20050095246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators' [patent_app_type] => utility [patent_app_number] => 10/972157 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9101 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095246.pdf [firstpage_image] =>[orig_patent_app_number] => 10972157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918697 [patent_doc_number] => 20050096258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Methods and compositions for treating gastrointestinal tract mucin production associated disease conditions' [patent_app_type] => utility [patent_app_number] => 10/967463 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15122 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096258.pdf [firstpage_image] =>[orig_patent_app_number] => 10967463 [rel_patent_id] =>[rel_patent_doc_number] =>)